NEW YORK (GenomeWeb News) – The Wellcome Trust Sanger Institute has purchased 11 more Illumina Genome Analyzers, Illumina announced today.
The San Diego-based firm said that the Sanger Institute now has 37 of its second-generation sequencing platforms.
“The Sanger Institute has an important international role in producing and analyzing genomic data,” Julian Parkhill, director of sequencing at the institute, said in a statement. “That role is founded in DNA sequencing and we will meet new challenges by investing in appropriate new technologies.”
Terms of the purchase were not disclosed.